openPR Logo
Press release

Quanta Biosciences and IDT partner to develop and produce microRNA PCR

03-22-2011 08:09 AM CET | Science & Education

Press release from: Integrated DNA Technologies

Quanta Biosciences (Gaithersburg, MD) has developed hundreds of assays for quantifying microRNAs, and has entered into a partnership with Integrated DNA Technologies (Coralville, IA) to custom manufacture them.

MicroRNAs have been shown to play a key role in cancer as well as many biological processes including neurological and cardiac function. Quanta’s portfolio of microRNA products will allow scientists to accurately detect and profile mature miRNA (miR) sequences. Early access customers have deployed Quanta’s microRNA assays for toxicology screening during drug development, and quality control of stem-cell pluripotency and differentiation. IDT, the Custom Biology Company and world leader in oligonucleotide synthesis, will produce the assays and supply them through an online catalog directly to Quanta’s customers. Quanta Biosciences has an entire line of microRNA cDNA synthesis and qPCR detection products at www.quantabio.com/mirna

About Quanta Biosciences
Quanta Biosciences has been developing and manufacturing life science reagents since 2001. Quanta’s portfolio includes the industry-first qScript™ cDNA SuperMix and PerfeCTa™ SuperMixes for qPCR and multiplex qPCR. Quanta’s reagents are used for gene expression, pathogen detection and genetic analysis applications in a variety of industries including pharmaceutical research and development, diagnostics, agribusiness and bio-defense. Quanta manufactures products in Gaithersburg, Maryland, and has distribution relationships worldwide. For more information visit quantabio.com.

About IDT
Integrated DNA Technologies, Inc. (IDT) is the largest supplier of custom nucleic acids in the world, serving the areas of academic research, biotechnology, clinical diagnostics and pharmaceutical development. IDT's primary business is the manufacturing of custom primers, probes, and genes for research and diagnostic applications. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information, visit www.idtdna.com.

Alto Marketing

Office 3 Universal Marina, Crableck Lane, Sarisbury Green, Southampton, SO31 7AL

IDT enquiries
Integrated DNA Technologies
Lynette Brown – Marketing Manager
t: +1 319-665-7208
e: lbrown@idtdna.com

Quanta enquiries
Quanta Biosciences Inc.
James Snook – VP Marketing
t: + 1 619 737 6777
e: james.snook@quantabio.com

Media enquiries
Alto Marketing Limited
Carolyn Butchers
t: +44 (0)1489 557672
e: carolynb@alto-marketing.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Quanta Biosciences and IDT partner to develop and produce microRNA PCR here

News-ID: 167454 • Views:

More Releases from Integrated DNA Technologies

Troubleshooting and Optimizing Mutagenesis
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides in-depth protocols and troubleshooting suggestions for your mutagenesis applications. As part of the new, free-to-download IDT Mutagenesis Applications Guide, an extensive troubleshooting section makes it possible to optimize your mutagenesis experiments for the best possible resulting data. Everything from primer design, reaction setup, ligation and transformation efficiency, to specific reaction components and PCR parameters, are covered. The guide provides
IDT DsiRNAs Used to Map Pain Pathways in the CNS
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, distributes the highly informative newsletter, DECODED. In this quarter’s edition the work carried out by Dr Philippe Sarret and colleagues is discussed in detail. Sarret’s laboratory is based at the Université de Sherbrooke (Quebec, Canada), where researchers are investigating novel ways to develop analgesics and are the first to attempt RNA interference (RNAi) via direct in vivo targeting of genes
IDT’s newsletter provides an insight into the therapeutic use of RNAi
Decoded issue 2 – Featuring an interview with Dr John Rossi Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has released the second issue of its educational and informative newsletter, Decoded. Available to download for free, the second issue of this quarterly newsletter includes a wealth of scientific content, and features an interview with Dr John Rossi (Department of Molecular and Cellular Biology and Beckman Research Institute of City
The IDT OligoCard for quick and simple ordering
Pre-payment card simplifies the oligonucleotide purchase process Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, makes it easy to purchase high quality oligonucleotides using its pre-pay OligoCard system. Credit can be easily transferred to an OligoCard using just a single PO or credit card transaction, minimizing paperwork. Oligos can then be ordered immediately, eliminating the delays associated with purchase authorization, maximizing efficiency. Transaction history is available online around the

All 5 Releases


More Releases for Quanta

Quanta Publishing Unveils "Amazing Robots!": The 2025 Science Fiction Anthology
Image: https://www.globalnewslines.com/uploads/2025/01/722fb2c42cfe0e83ee12338f72ca589d.jpg Quanta Publishing proudly announces the release of its 2025 Science Fiction Anthology, "Amazing Robots!"-a dazzling collection that explores the tantalizing theme of non-human autonomy. From the earliest days of industrialization, the concept of thinking machines has captivated the human imagination, triggering a blend of wonder and dread. As society inches closer to the seamless integration of artificial intelligence and autonomous machines into everyday life, Quanta Publishing invites readers to ponder
Medical Laser Systems Market 2020 Precise Outlook | Lumenis, Quanta System, Cyno …
The Global Medical Laser Systems Market Research Report 2020-2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report. According
Medical Laser Systems Market 2020 Precise Outlook | Lumenis, Quanta System, Cyno …
The Global Medical Laser Systems Market Research Report 2020-2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report. According
Automotive ECU Market 2020 Precise Outlook | Lumenis, Quanta System, Cynosure
The Global Automotive ECU Market Research Report 2020-2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report. According to
PEGylated Proteins Market 2025 | Merck Millipore, NOF Corporation, Creative PEGw …
Global PEGylated Proteins Market: Overview Proteins have found application in the therapeutics industry for long and are much sought after in modern medicine too. This has resulted in a growing number of protein-based drugs in market these days. However, there are quite a few pressing problems associated with their use such as swift degradation and excretion from patients, requiring frequent dosing. This ups the cost of therapy. To tackle the challenege,
Global White Box Server Market 2018 - Quanta, Wistron, Inventec, Hon Hai, MiTAC
The competitive framework study Global White Box Server Market is an in-depth study that covers all the aspects of the industry. The research report delivers key insights verified by key industry participants. These include market-leading participants, key clients and consumers, and product types and applications.As per the world economic growth, the White Box Server market size is estimated from xxx million $ in 2014 to xxx million $ in 2017.The